Work Here?
Industries
Healthcare
Company Size
501-1,000
Company Stage
Series E
Total Funding
$441.6M
Headquarters
Burlingame, California
Founded
2014
Color provides genetic testing and health screening services aimed at making healthcare more accessible and affordable. The company offers a variety of tests, including those for COVID-19, which help individuals learn about their genetic risks for different health conditions. Consumers can purchase these tests directly from Color's website, while healthcare providers can order them for their patients. Additionally, Color collaborates with employers to create personalized health programs that enhance employee wellness and productivity. A key aspect of Color's service is its commitment to security and privacy, ensuring that personal health information is safeguarded. The company also provides genetic counseling to assist individuals in interpreting their test results and making informed health choices. Color's goal is to promote preventive healthcare through genetic insights, distinguishing itself from competitors by focusing on both individual consumers and workplace health initiatives.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$441.6M
Above
Industry Average
Funded Over
5 Rounds
Industry standards
Competitive salary
Comprehensive medical, dental, vision, life, and disability benefits. Including employer HSA contributions.
401(k) match
Monthly lunch, phone, and wifi stipend for remote employees
Generous vacation policy, paid holidays and company-wide recharge days
Monthly stipend to spend on your well being
Equal paid parental leave for birthing and non-birthing parents
Four complementary clinical-grade genetic testing kits for you and your family
What You Should Know:– Color Health, a provider of precision health solutions released its second annual Employer Insights Report, revealing a disconnect between employer priorities and the reality of cancer care benefits offered to employees.– The survey, conducted by The Harris Poll, explores how benefits leaders make decisions regarding cancer program benefits, including their current offerings, perceived effectiveness, and strategies for managing costs.Disconnect Between Employer Priorities and Cancer Care OfferingsThe survey revealed that employers’ cancer programs remain largely focused on treatment and management, despite benefits leaders recognizing the need for a more comprehensive approach to cancer care. Leaders emphasized the importance of resources beyond what is provided through their health plans, particularly for prevention, early detection, and post-treatment support.Key findings of the report include:88% of benefits leaders advocated for greater investment in prevention and early detection initiatives , a sentiment that persisted in 2024. In practice, though, 82% of benefits leaders reported spending significantly more on cancer treatment and management programs in 2023—a number that remained almost unchanged (81%) in 2024., a sentiment that persisted in 2024. In practice, though, 82% of benefits leaders reported spending significantly more on cancer treatment and management programs in 2023—a number that remained almost unchanged (81%) in 2024. 9 in 10 benefits leaders (91%) agreed that organizations should prioritize early detection and survivorship support alongside active cancer management, fewer than half (43%) have offered comprehensive cancer benefits as a strategy for reducing costs.About three in four benefits leaders feel the need to expand their cancer offerings beyond what’s currently provided through their health plans (75%) or primary care providers (72%)—but only about 1 in 4 do, typically focusing on point solutions like survivorship support (27%) or genetic testing (24%) rather than comprehensive programs.beyond what’s currently provided through their health plans (75%) or primary care providers (72%)—but only about 1 in 4 do, typically focusing on point solutions like survivorship support (27%) or genetic testing (24%) rather than comprehensive programs. Benefits leaders identified the most critical cancer care benefits as: cancer screening and early detection (73%), treatment center networks and center of excellence (CoE) programs (67%), and cancer risk assessments (66%).cancer screening and early detection (73%), treatment center networks and center of excellence (CoE) programs (67%), and cancer risk assessments (66%)
Younger Employees Face Increasing Cancer Risks, but HR Leaders Lack Comprehensive ResourcesBURLINGAME, Calif., Feb. 4, 2025 /PRNewswire/ -- Color Health today announced findings from its second annual survey, conducted by The Harris Poll. The survey explores how benefits leaders navigate decision-making regarding cancer program benefits, including their current offerings, perceived effectiveness, and strategies for managing costs. Details are available in Color's Employer Insights Report 2025: The State of Cancer.Over 2 million Americans will be diagnosed with cancer this year according to the American Cancer Society's 2025 Cancer Facts & Figures report. Rising incidence among working-aged individuals could have a significant impact on the workplace—and U.S. businesses as a whole—especially as healthcare costs are projected to jump by eight percent this year, the highest rate in a decade.The survey revealed that employers' cancer programs remain largely focused on treatment and management, despite benefits leaders recognizing the need for a more comprehensive approach to cancer care
The American Cancer Society (ACS) and Color Health today announced the launch of their new pilot program to provide free at-home colorectal cancer screening kits to individuals in rural areas and other underserved communities, where barriers to healthcare access often hinder timely screening and early detection.
What You Should Know:– The American Cancer Society (ACS) and Color Health have joined forces to launch a new pilot program aimed at increasing access to colorectal cancer screening in underserved communities.– The program, recognized by the White House Office of Science and Technology Policy, seeks to address disparities in cancer outcomes and improve early detection rates.The Importance of Colorectal Cancer Early DetectionColorectal cancer is highly treatable when detected early. However, many Americans continue to be diagnosed at late stages, leading to poorer outcomes. The program seeks to close these access gaps by providing free at-home fecal immunochemical test (FIT) kits to eligible individuals.How the Program WorksDistribution: Participating Federally Qualified Health Centers (FQHCs) and community clinics in rural and non-urban areas will receive FIT kits to distribute to eligible patients at no cost.Participating Federally Qualified Health Centers (FQHCs) and community clinics in rural and non-urban areas will receive FIT kits to distribute to eligible patients at no cost. Patient Support: Color Health will provide comprehensive support throughout the screening process, including test activation, result delivery, and care coordination.Color Health will provide comprehensive support throughout the screening process, including test activation, result delivery, and care coordination. Results Sharing: Test results will be securely shared with healthcare providers, ensuring timely follow-up for patients with abnormal findings.Benefits for Clinics and PatientsFree Access: The program is entirely free for both clinics and patients, eliminating financial barriers to screening.The program is entirely free for both clinics and patients, eliminating financial barriers to screening. Enhanced Community Health: Participating clinics can improve access to cancer screening services for their patients, contributing to overall community health.Participating clinics can improve access to cancer screening services for their patients, contributing to overall community health
- The American Cancer Society (ACS) and Color Health have joined forces to launch a new pilot program aimed at increasing access to colorectal cancer screening in underserved communities.
Find jobs on Simplify and start your career today
Industries
Healthcare
Company Size
501-1,000
Company Stage
Series E
Total Funding
$441.6M
Headquarters
Burlingame, California
Founded
2014
Find jobs on Simplify and start your career today